trends. This report offers an analysis of the impact of those trends, and reforms and regulations, particularly in the U.S. and the EU. Key Trends Explored: - Generic drug manufacturers are gearing up to take advantage of the opportunities presented by the many patent expiries - What trends are impacting the leading generic drug manufacturers such as Teva, Sandoz, and others - What government regulations and policies will effect pharma company bottomlines in 2012 and beyond? - How
Words: 354 - Pages: 2
Gurbax's names. Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies world wide. The Company serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in
Words: 1274 - Pages: 6
structure of Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units with severe price competition and government price control. There are about 3,000 pharmaceutical manufacturers, the vast majority of which focus on generic drugs. The major players in the industry are Ranbaxy, Cipla, Dr. Reddy's Laboratories, Lupin, Nicolas Piramal,Aurobindo Pharma, Cadila Pharmaceuticals, Sun Pharma, W Wockhardt Ltd. and Aventis Pharma. The industry encourages international interest
Words: 257 - Pages: 2
protected by patents, by paying rivals large sums of money from producing cheaper, alternative drugs. In an article written by Marian Wang, she discusses a particular case in which Pfizer makes “…a deal with certain pharmacy benefit managers … to block generic versions of Lipitor.”(Wang, Pfizer’s Latest Twist on ‘Pay for Delay’) There are a few ethical issues with this: one, the rival companies are infringing on patent laws, two, larger pharmaceutical companies are trying to create as much profit for their
Words: 1413 - Pages: 6
have do not have insurance or were previously denied coverage. This reform will provide opportunities for many industries but specifically, the pharmaceutical industry will see much growth. However, one must look at the effect on brand-name and generic drug manufacturers individually to fully understand the ramifications. Overall, healthcare reform is a large growth opportunity for the pharmaceutical industry and research shows a great deal of support for the legislation. In 2009, pharmaceutical
Words: 977 - Pages: 4
Do generic products really save you money? With the price of living getting higher and higher as very year passes, people are looking for alternative ways to save money. The main reason for buying generic products, saving money, is simple enough. But there's also the satisfaction of not giving in to the marketing hype and buying something just because a company promotes it everywhere. The generic labels may not be as fancy as the brand-name products, and the taste of generic items, such as soda
Words: 1103 - Pages: 5
INTRODUCTION Generic brands are a rapidly growing part of the market today. Increases in costs to suppliers and distributers have caused a decline in profit for national brands. In the interest of lowering costs and increasing profit, it is beneficial for North Star to consider the potential of generic brand sales. To ensure that North Star is equipped to make the best decisions regarding entering the generic brands market, sales manager Paul Gettisfield authorized this report on July 8, 2011
Words: 984 - Pages: 4
have increased in price by 17.7% from 2010 to 2011 and generic drugs have actually decreased in cost by -7.2% for the same years from the same HCCI report. Generic drugs have had an increase in utilization from consumers’ while brand name has decreased and this is why pharmaceuticals have raised prices on the brand name drugs and generics have gone down. Consumers’ are realizing that this is price gauging and are attempting to go with generic if possible. One reason that drug prices are so high
Words: 2836 - Pages: 12
An Introduction to R Notes on R: A Programming Environment for Data Analysis and Graphics Version 3.2.0 (2015-04-16) W. N. Venables, D. M. Smith and the R Core Team This manual Copyright c Copyright c Copyright c Copyright c Copyright c is for R, version 3.2.0 (2015-04-16). 1990 W. N. Venables 1992 W. N. Venables & D. M. Smith 1997 R. Gentleman & R. Ihaka 1997, 1998 M. Maechler 1999–2015 R Core Team Permission is granted to make and distribute verbatim copies of this manual
Words: 8172 - Pages: 33
[pic] Table of Contents Executive Summary 2-6 External Analysis 7-13 Internal A ,mnalysis 14-17 Functional Analysis 18-21 Business-Level Strategy 22-24 Corporate Level Strategy 25-27 Strategy Implementation 28-30 References 31 Executive Summary A Customer’s Hope Eli Lilly and Company is on a mission that benefits millions of people every day by helping them live longer and fuller lives. They provide their customers with
Words: 11111 - Pages: 45
